Regeneron Pharmaceuticals Down Over 8%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
January 09 2023 - 10:40AM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $673.00,
down $64.15 or 8.7%
--Would be lowest close since Sept. 7, 2022, when it closed at
$596.44
--On pace for largest percent decrease since March 20, 2020,
when it fell 10.49%
--Currently down three of the past five days
--Down 6.72% month-to-date
--Down 6.72% year-to-date
--Down 12.19% from its all-time closing high of $766.39 on Dec.
2, 2022
--Up 8.33% from 52 weeks ago (Jan. 10, 2022), when it closed at
$621.27
--Down 12.19% from its 52-week closing high of $766.39 on Dec.
2, 2022
--Up 22.73% from its 52-week closing low of $548.35 on June 14,
2022
--Traded as low as $668.00; lowest intraday level since Sept. 8,
2022, when it hit $652.64
--Down 9.38% at today's intraday low; largest intraday percent
decrease since March 20, 2020, when it fell as much as 11.19%
--Worst performer in the S&P 500 today
--Second worst performer in the Nasdaq 100 today
All data as of 10:07:27 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 09, 2023 10:25 ET (15:25 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Apr 2023 to Apr 2024
